Biogen
BIIB
BIIB
997 hedge funds and large institutions have $33.5B invested in Biogen in 2023 Q4 according to their latest regulatory filings, with 133 funds opening new positions, 285 increasing their positions, 374 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more capital invested
Capital invested by funds: $32B → $33.5B (+$1.52B)
24% less repeat investments, than reductions
Existing positions increased: 285 | Existing positions reduced: 374
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
Holders
997
Holding in Top 10
10
Calls
$645M
Puts
$499M
Top Buyers
| 1 | +$545M | |
| 2 | +$408M | |
| 3 | +$156M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$148M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$146M |
Top Sellers
| 1 | -$108M | |
| 2 | -$88.4M | |
| 3 | -$80.5M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$66.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$62.6M |